Correction: update to implant date.Added device catalog and lot numbers.An event regarding fretting involving a accolade stem was reported.The event was not confirmed.Method & results product evaluation and results: material analysis, visual, functional and dimensional inspections could not be performed as the device was not returned.Medical records received and evaluation: a review of the provided medical information by a clinical consultant indicated: there is no examination of explanted components and no surgical pathology report confirming a diagnosis of metalosis/trunnionosis or altr.The description of pain in the right hip ¿since surgery¿ would preclude trunnionosis or metalosis as the cause at the immediate post-operative period.Moderately elevated plasma ion levels may relate to the longstanding left total hip arthroplasty and should not be a primary indication for revision surgery.No operative report for the stated 2016 surgery for greater trochanteric debridement and heterotopic ossification excision is available, and the recurrence of these symptoms are noted.There is no evidence that either the october 9, 2018 revision surgery or the october 30, 2018 hematoma i&d surgery were related to factors of implant design, manufacturing or materials.Product history review: a review of the device manufacturing records indicate that all devices accepted into final stock were free from discrepancies.-complaint history review: there have been no other similar events for the lot referenced.Conclusions: medical review could not confirm the reported diagnosis of metalosis/trunnionosis.Return of the device and pathology reports are needed to complete the investigation for determining root cause.No further investigation for this event is possible at this time.If devices and / or additional information become available to indicate further evaluation is warranted, this record will be reopened.
|